LIP
CHRS icon

Lighthouse Investment Partners’s Coherus Oncology CHRS Stock Holding History

Lighthouse Investment Partners’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-313,134
Closed -$1.04M – 392
2023
Q4 		$1.04M Buy
+313,134
New +$839K 0.05% 227

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Lighthouse Investment Partners's CHRS Position: Q1 2024 in Review

Lighthouse Investment Partners sold out of Coherus Oncology (CHRS) in Q1 2024, closing a stake of 313,134 shares — an estimated $1.04M sold.

Lighthouse Investment Partners first reported a position in CHRS in Q4 2023 and held it in 1 quarter. The position peaked at $1.04M in Q4 2023. 137 funds tracked by Wall St. Rank hold CHRS as of Q1 2024.

  • Lighthouse Investment Partners reported no remaining Coherus Oncology position as of Q1 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 313,134 Coherus Oncology shares in Q1 2024, an estimated $1.04M.
  • Lighthouse Investment Partners first reported a position in Coherus Oncology in Q4 2023 and held it in 1 quarter.
  • Lighthouse Investment Partners's Coherus Oncology position peaked at $1.04M in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2024.

Based on Lighthouse Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.